Target intelligence / Profile preview

Novel transcript, antisense to RND3

Molecular classification
Other (Natural antisense transcript; non-coding RNA)
01

Overview

This entry describes a non-coding RNA whose sequence is antisense to the RND3 gene. Natural antisense transcripts (NATs) like this can regulate expression of adjacent or overlapping genes through various mechanisms, including modulation of chromatin state, transcriptional interference, and masking of miRNA-binding sites[1][2][3][4][5]. However, this particular transcript does not have a well-defined protein-coding function or established direct link to disease or drug targeting. Its biological activity, if any, would be regulatory in nature and dependent on effects on RND3 gene expression or chromatin environment. The attribution "novel transcript" suggests it is computationally or experimentally identified but not necessarily functionally characterized. The provided Ensembl gene ID does not map to a standard, stable annotated gene and may indicate provisional or outdated nomenclature. In summary, "novel transcript, antisense to RND3" is most accurately described as a non-coding antisense RNA of unclear clinical or experimental significance, not a targetable receptor or enzyme.

Other names
NAT antisense to RND3antisense RNA to RND3natural antisense transcript to RND3
02

Biological functions

Regulation of gene expression (including transcriptional and post-transcriptional regulation)
03

Disease associations

Other (Potentially disease-related via regulatory influence on RND3, but not directly characterized)

Beyond the preview

Go deeper on Novel transcript, antisense to RND3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to RND3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call